Skip to content


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page

Novo Nordisk: Establishing a strategic innovation unit

PA Consulting Group helped Novo Nordisk, one of the world's largest insulin manufacturers, to embark on an ambitious business strategy of becoming more than a developer of insulin and insulin delivery devices; to become a company that patients would turn to to manage their diabetes - a ‘preferred diabetes company'.

Traditionally, Novo Nordisk's insulin developers had worked separately from those involved in delivering the insulin to the patient. To achieve the company's new focus on the patient, these two groups were brought together in a new division called Protein Delivery Systems.

PA helped overcome some major challenges including the integration of two existing groups and new recruits; alignment with the overall strategy; the creation of a unique culture; and progressing innovation.


"A year ago PDS was an idea, now it's business as usual."

Lars Guldbæk Karlsen Senior Vice President

See how PA_Consulting established a strategic #innovation unit for @novonordisk #makethedifference

Contact the life sciences team

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.